Lobectomy for Lung Cancer: 165 Real Stories

165 stories match lung cancer and lobectomy. 77 of them mention chemotherapy.

Cancer Stories

A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Lung adenocarcinoma surgery complicated by postoperative chest wall hernia

Patient Info: Anonymized, Male, 70+

He completed VATS left lower lobectomy for lung adenocarcinoma and later mesh repair of a postoperative chest wall hernia; at 6 months after hernia repair, the hernia had not recurred.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Localized lung adenocarcinoma: lobectomy followed by air-leak repair

Patient Info: Anonymized, Male, 60s

After lobectomy and a second thoracoscopic repair for persistent postoperative air leak, the air leak resolved by postoperative day 3 and had not recurred at 2-month follow-up.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage III Non-Small Cell Lung CancerLung Cancer

Stage IIIA EGFR lung adenocarcinoma: no recurrence after early osimertinib stop

Patient Info: Anonymized, Female, 70+ | Stage III

Biomarkers: EGFR exon 19 deletion mutation; elevated KL-6 and SP-D during interstitial lung disease episode

During 9 months of follow-up after osimertinib was stopped, she had no recurrence of interstitial lung disease, pulmonary embolism, or non-small cell lung cancer.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Lung CancerLung Cancer

Localized sarcomatoid lung carcinoma: no recurrence 14 months after lobectomy

Patient Info: Anonymized, Male, 50s

Biomarkers: No molecular biomarkers reported; histopathology confirmed sarcomatoid carcinoma

As of May 2025, the patient remained in good health with no evidence of recurrence 14 months after video-assisted thoracoscopic left lower lobectomy.

PubMed Central
OutcomeCancer-Free / NED
Leah, who was diagnosed with Stage IV Lung CancerLung Cancer

How We Got Here: 6 Young Lung Cancer Patients & Their Paths To Surgery- Part 1

Patient Info: Leah Phillips, Female | Stage IV

Biomarkers: EGFR exon 19 deletion

Metastatic Site: bone (pelvis; spine; ribs)

As of April 2025, Leah was living with Stage IV EGFR exon 19 deletion lung cancer while continuing Tagrisso after SBRT and right middle lobe lobectomy.

YouTube (JA search)
OutcomeLiving With Cancer
A patient, who was diagnosed with Lung CancerLung Cancer

Synchronous Stage I lung adenocarcinomas: VATS surgery with clear margins

Patient Info: Anonymized, Male, 70+

He completed surgical treatment with negative lymph nodes and clear margins, was discharged on postoperative day 9, and was planned for surveillance with his respiratory physician.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage I Lung AdenocarcinomaLung Cancer

Clinical Stage IB lung adenocarcinoma: no recurrence after thoracoscopic lobectomy and pneumatocele repair

Patient Info: Anonymized, Male, 60s | Stage I

Biomarkers: No molecular biomarkers reported; tumor markers were normal: CEA 2.1 ng/mL, SCC antigen 1.5 ng/mL, cytokeratin 19 fragment 0.9 ng/mL

As of March 2025, the patient had no recurrence after thoracoscopic left lower lobectomy for lung adenocarcinoma; postoperative pneumatocele-related air leak resolved with reinforcement and adhesive therapy.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

EGFR-Mutant Lung Adenocarcinoma That Transformed to Small Cell Lung Cancer

Patient Info: Anonymized, female, 40s | Stage IV

Biomarkers: EGFR exon 19 deletion; acquired EGFR T790M mutation

Metastatic Site: liver

The cancer progressed after transformation to small cell lung cancer, and she died 49 months after the original diagnosis.

PubMed Central
OutcomeIn Memory
A patient, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

HER2 exon 20 metastatic lung adenocarcinoma with pathologic complete response after chemoimmunotherapy and surgery

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: HER2 exon 20 insertion lung adenocarcinoma with TP53 mutation, PD-L1 TPS 50%, and low TMB.

Metastatic Site: contralateral lung

Right lower lobectomy with radical lymphadenectomy in November 2023 showed pathologic complete response, and no additional therapy was offered after surgery.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Stage 4 lung adenocarcinoma with RET fusion responding to pralsetinib

Patient Info: Anonymized, Male, 60s | Stage IV

Biomarkers: RET fusion

Metastatic Site: pleura

As of March 2025, he had recovered from grade 3 Pneumocystis jirovecii pneumonia, restarted pralsetinib, and had no progressive disease or recurrence of adverse events over 13 months.

PubMed Central
OutcomeResponding Well
Stephanie, who was diagnosed with Stage II Non-Small Cell Lung CancerLung Cancer

Stage II ALK Non-Small Cell Lung Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female | Stage II

Biomarkers: ALK-rearranged

As of January 2025, Stephanie had clean scans and bloodwork for 3 years after Stage IIB ALK-positive lung adenocarcinoma treated with surgery, 4 rounds of chemotherapy, and ongoing daily targeted therapy.

The Patient Story
OutcomeCancer-Free / NED
Stephanie, who was diagnosed with Stage II Lung AdenocarcinomaLung Cancer

Stage II ALK Lung Adenocarcinoma: Stephanie's Patient Story

Patient Info: Stephanie Williams, Female | Stage II

Biomarkers: ALK-rearranged

Stephanie had clean scans nearly 3 years after diagnosis but remained on daily ALK-targeted therapy to reduce recurrence risk.

The Patient Story
OutcomeCare Ongoing
A patient, who was diagnosed with Lung AdenocarcinomaLung Cancer

Lung Cancer Surgery Followed by Severe Arm Ischemia and Amputation

Patient Info: Anonymized, female

A woman in her mid-60s underwent surgery for lung adenocarcinoma and then developed severe arterial-line-related arm ischemia that ultimately required an above-elbow amputation.

PubMed Central
OutcomeNot reported
A patient, who was diagnosed with Stage II Lung Squamous Cell CarcinomaLung Cancer

Stage IIIA squamous lung cancer: surgery after nivolumab-related complications

Patient Info: Anonymized, Female, 70+ | Stage II

Biomarkers: PD-L1 TPS 99% before treatment; PD-L1 TPS 70% in postoperative hilar lymph node; TPOAb and TgAb normal during thyroiditis workup

As of January 2025, the patient had no recurrence 7 months after neoadjuvant nivolumab/carboplatin/paclitaxel and 5 months after thoracoscopic right upper lobectomy with lymph node dissection.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Small Cell Lung CancerLung Cancer

Lung Adenocarcinoma That Transformed to Small Cell Cancer After Recurrence

Patient Info: Anonymized, male, 60s | Stage IV

Biomarkers: PD-L1 1%-24%; no druggable driver alteration identified

Metastatic Site: brain, liver

After treatment for the small-cell-transformed recurrence, the liver metastases showed sustained regression and progression-free survival had reached 13 months by September 2024.

PubMed Central
OutcomeResponding Well
A patient, who was diagnosed with Stage III Lung Squamous Cell CarcinomaLung Cancer

Stage 3 squamous cell lung cancer: major response to chemo-immunotherapy

Patient Info: Anonymized, Male, 70+ | Stage III

Biomarkers: PD-L1 30-40%

After neoadjuvant chemoimmunotherapy and sleeve right lower lobectomy, pathology showed major pathological response with negative margins, and no metastasis or recurrence was observed 6 months after surgery.

PubMed Central
OutcomeCancer-Free / NED